LR Health & Beauty SE announced its preliminary financial results for 2025. Total sales for full-year 2025 are now expected to reach $328 million, solidly in line with previously released guidance of $327 million to $333 million.

USANA Health Sciences, Inc. released its preliminary fiscal year 2025 net sales results. Net sales during the period are expected to reach approximately $925 million, beating its previously issued guidance of $920 million.

Zinzino announced its preliminary sales results for 2025. Group revenue increased 46% in the fourth quarter, reaching $113 million, and contributing to a full year 2025 revenue increase of 51%, when compared to 2024.

Oriflame announced its recapitalization transaction was successfully executed. With this completed, the company now has the opportunity to restructure is debt and capital structure. New financing terms, which include updated loan and bond arrangements, will now be in place, which Oriflame believes will strengthen its balance sheet and support its long-term operations.

Oriflame announced that it has successfully obtained the necessary number of bondholder consents to approve amendments to its outstanding debt as part of its recapitalization plan.

Shaklee reported one of its strongest periods of growth in its 70-year history. The company described this momentum as “record-breaking growth” and reported an average increase of 29% year-over-year improvement in US and Canada for the month of November.